Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply

Aliment Pharmacol Ther. 2022 Apr;55(8):1064. doi: 10.1111/apt.16884.

Authors

Mohammed Deputy^{1

2}, Ailsa Hart³, Omar Faiz^{1

2}

Affiliations

¹ Surgical Epidemiology, Trials and Outcome Centre, St Mark's Hospital and Academic Institute, Harrow, UK.
² Department of Surgery and Cancer, Imperial College London, London, UK.
³ Department of Gastroenterology, St Mark's Hospital and Academic Institute, Harrow, UK.

Abstract

This article is linked to Deputy et al papers. To view these articles, visit https://doi.org/10.1111/apt.16800 and https://doi.org/10.1111/apt.16841

Publication types

Letter
Comment

MeSH terms

COVID-19*
Chronic Disease
Colitis*
Humans
Inflammatory Bowel Diseases* / epidemiology
Inflammatory Bowel Diseases* / therapy
Pandemics